Taken together, the BNIP3/Nix pathway provides a novel idea to ameliorate mitochondrial damage and reduce fibrosis in renal tubular cells, providing a potential target for the treatment and prevention of CKD. Here, BNIP3 is linked to chronic kidney disease.